Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA.
Autorzy:
Kjær IM; Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark. ina.mathilde.kjaer@rsyd.dk.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. ina.mathilde.kjaer@rsyd.dk. Kahns S; Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Timm S; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Andersen RF; Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Madsen JS; Department of Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Jakobsen EH; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Medicine, Hospital Soenderjylland, University Hospital of Southern Denmark, Aabenraa, Denmark. Tabor TP; Department of Pathology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Pathology, Viborg Hospital, Regional Hospital Central Jutland, Viborg, Denmark. Jakobsen A; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Bechmann T; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Oncology, Regional Hospital West Jutland, Herning, Denmark.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 24; Vol. 13 (1), pp. 8419. Date of Electronic Publication: 2023 May 24.
Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer.
Autorzy:
Kjær IM; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. ina.mathilde.kjaer@rsyd.dk.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. ina.mathilde.kjaer@rsyd.dk. Olsen DA; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Brandslund I; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Bechmann T; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.; Department of Oncology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Jakobsen EH; Department of Oncology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Bogh SB; OPEN, Open Patient Data Explorative Network, Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Madsen JS; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Oct 06; Vol. 10 (1), pp. 16558. Date of Electronic Publication: 2020 Oct 06.
Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study.
Autorzy:
Kjær IM; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. ina.mathilde.kjaer@rsyd.dk.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. ina.mathilde.kjaer@rsyd.dk. Olsen DA; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Brandslund I; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Bechmann T; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.; Department of Oncology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Jakobsen EH; Department of Oncology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark. Bogh SB; OPEN, Open Patient data Explorative Network, Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Madsen JS; Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Apr 21; Vol. 10 (1), pp. 6714. Date of Electronic Publication: 2020 Apr 21.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
